Improvements to joints and skin see Taltz outscore Humira
A head to head clinical trial win by potential PsA treatment Taltz could boost the fortunes of Eli Lilly.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more